Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-01-03
1998-11-03
Huff, Sheela
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 235, 530350, 4353201, 435 691, 435 693, 435 6, 435273, 4352523, C07H 2102, C07H 2104
Patent
active
058310495
ABSTRACT:
The present invention provides a human thioredoxin (TRDX) and polynucleotides which identify and encode TRDX. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding TRDX and a method for producing TRDX. The invention also provides for agonists, antibodies, or antagonists specifically binding TRDX, and their use, in the prevention and treatment of diseases associated with expression of TRDX. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding TRDX for the treatment of diseases associated with the expression of TRDX. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding TRDX in the production of recombinant proteins. The invention also provides for the use of purified TRDX in the production of recombinant proteins. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding TRDX.
REFERENCES:
Loferer, H., et al., "A Bacterial Thioredoxin-like Protein That Is Exposed to the Periplasm Has Redox Properties Comparable with Those of Cytoplasmic Thioredoxins," The Journal of Biological Chemistry, 270(44):26178-26183.
Holmgren, A., "Thioredoxin," Ann. Rev. Biochem., 54:237-271 (1985).
Abate, C., et al., "Redox Regulation of Fos and Jun DNA-Binding Activity in Vitro," Science, 249:1157-1161 (1990).
Tagaya, Y., et al., "ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction," The EMBO Journal, 8(3)757-764 (1989).
Wakasugi, H., et al., "Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor," Proc. Natl. Acad. Sci. USA, 84:804-808 (1987).
Rosen, A., et al., "A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin," International Immunology, 7(4) 625-633 (1994).
Miranda-Vizuete, A., et al., "The Levels of Ribonucleotide Reductase, Thioredoxin, Glutaredoxin 1, and GSH are Balanced in Escherichia coli K12*," The Journal of Biological Chemistry, 271(32) 19099-19103 (1996).
Yamauchi, A., et al., "Lymphocyte Transformation and Thiol Compounds; the Role of ADF/Thioredoxin as an Endogenous Reducing Agent," Molecular Immunology, 29(2):263-270 (1992).
Watabe, S. (GI 1545817) GenBank Sequence Database (Accession N30487) National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland 2084.
Luthman, M., et al., "Rat Liver Thioredoxin and Thioredoxin Reductase: Purification and Characterization," Biochemistry, 21:6628-6633.
Goli Surya K.
Hillman Jennifer L.
Billings Lucy J.
Huff Sheela
Incyte Pharmaceuticals Inc.
Mohan-Peterson Shella
LandOfFree
Human thioredoxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human thioredoxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human thioredoxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-690630